Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL® 2 study

Published: 17 October 2024| Version 1 | DOI: 10.17632/x4bmwhd8h6.1
Contributors:
Kenneth Gordon, Matthias Augustin, Jonathan Barker, Yayoi Tada, Mark Lebwohl, Ming Tang, Patrick Hofmann, Christian Thoma, Alice Gottlieb

Description

Supplement material

Files

Categories

Psoriasis

Funding

Boehringer Ingelheim

Licence